IBDEI0WW ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16305,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,16306,0)
 ;;=564.1^^105^1017^8
 ;;^UTILITY(U,$J,358.3,16306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16306,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,16306,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,16306,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,16307,0)
 ;;=211.3^^105^1017^9
 ;;^UTILITY(U,$J,358.3,16307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16307,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,16307,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,16307,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,16308,0)
 ;;=533.90^^105^1017^10
 ;;^UTILITY(U,$J,358.3,16308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16308,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,16308,1,4,0)
 ;;=4^ULCER, PEPTIC
 ;;^UTILITY(U,$J,358.3,16308,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,16309,0)
 ;;=535.00^^105^1017^3
 ;;^UTILITY(U,$J,358.3,16309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16309,1,3,0)
 ;;=3^535.00
 ;;^UTILITY(U,$J,358.3,16309,1,4,0)
 ;;=4^GASTRITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,16309,2)
 ;;=^270169
 ;;^UTILITY(U,$J,358.3,16310,0)
 ;;=070.54^^105^1017^6
 ;;^UTILITY(U,$J,358.3,16310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16310,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,16310,1,4,0)
 ;;=4^HEPATITIS C,CHRONIC,W/O COMA
 ;;^UTILITY(U,$J,358.3,16310,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,16311,0)
 ;;=553.9^^105^1017^7
 ;;^UTILITY(U,$J,358.3,16311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16311,1,3,0)
 ;;=3^553.9
 ;;^UTILITY(U,$J,358.3,16311,1,4,0)
 ;;=4^HERNIA
 ;;^UTILITY(U,$J,358.3,16311,2)
 ;;=^56659
 ;;^UTILITY(U,$J,358.3,16312,0)
 ;;=455.6^^105^1017^5
 ;;^UTILITY(U,$J,358.3,16312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16312,1,3,0)
 ;;=3^455.6
 ;;^UTILITY(U,$J,358.3,16312,1,4,0)
 ;;=4^HEMORRHOIDS NOS
 ;;^UTILITY(U,$J,358.3,16312,2)
 ;;=^123922
 ;;^UTILITY(U,$J,358.3,16313,0)
 ;;=607.84^^105^1018^7
 ;;^UTILITY(U,$J,358.3,16313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16313,1,3,0)
 ;;=3^607.84
 ;;^UTILITY(U,$J,358.3,16313,1,4,0)
 ;;=4^IMPOTENCE, ORGANIC ORIGN
 ;;^UTILITY(U,$J,358.3,16313,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,16314,0)
 ;;=592.0^^105^1018^8
 ;;^UTILITY(U,$J,358.3,16314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16314,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,16314,1,4,0)
 ;;=4^KIDNEY STONES
 ;;^UTILITY(U,$J,358.3,16314,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,16315,0)
 ;;=185.^^105^1018^11
 ;;^UTILITY(U,$J,358.3,16315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16315,1,3,0)
 ;;=3^185.
 ;;^UTILITY(U,$J,358.3,16315,1,4,0)
 ;;=4^PROSTATE, MALIGN NEOPLASM
 ;;^UTILITY(U,$J,358.3,16315,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,16316,0)
 ;;=599.0^^105^1018^12
 ;;^UTILITY(U,$J,358.3,16316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16316,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,16316,1,4,0)
 ;;=4^URINARY TRACT INFECTION
 ;;^UTILITY(U,$J,358.3,16316,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,16317,0)
 ;;=V10.46^^105^1018^6
 ;;^UTILITY(U,$J,358.3,16317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16317,1,3,0)
 ;;=3^V10.46
 ;;^UTILITY(U,$J,358.3,16317,1,4,0)
 ;;=4^HX-PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,16317,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,16318,0)
 ;;=600.3^^105^1018^5
 ;;^UTILITY(U,$J,358.3,16318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16318,1,3,0)
 ;;=3^600.3
 ;;^UTILITY(U,$J,358.3,16318,1,4,0)
 ;;=4^CYST OF PROSTATE
 ;;^UTILITY(U,$J,358.3,16318,2)
 ;;=^322241
 ;;^UTILITY(U,$J,358.3,16319,0)
 ;;=600.00^^105^1018^2
 ;;^UTILITY(U,$J,358.3,16319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16319,1,3,0)
 ;;=3^600.00
